The specific immune contexture in sarcoma is often marked by predominate tumor-associated macrophages (TAM), dysfunctional tumor-infiltrating lymphocytes (TIL) with reduced CD8+ T and NK cell activity, increased regulatory T cells (Tregs), limited B cells, and impaired dendritic cell (DC) function. This evidence concerns the gene CD8A and sarcoma.